A Study Comparing AT-101 in Combination With Docetaxel and Prednisone Versus Docetaxel and Prednisone in Men With Chemotherapy-Naïve Metastatic Hormone Refractory Prostate Cancer (HRPC)
Clinical trial NCT00571675 · COMPLETED
Trial details
- NCT number
- NCT00571675
- Sponsor
- Ascenta Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-10-01
- Primary completion
- 2010-09-01
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.